Therapeutic effects of molecular hydrogen for a wide range of disease models and human
diseases have been investigated since 2007. A total of 321 original articles have been …

Since the 2007 discovery that molecular hydrogen (H 2) has selective antioxidant properties,
multiple studies have shown that H 2 has beneficial effects in diverse animal models and …

Myocardial ischemia/reperfusion injury (MIRI) is the major cause of myocardial cell damage
in acute myocardial infarction, and its treatment remains a clinical challenge. Ginsenoside …

Early brain injury (EBI), highlighted with inflammation and apoptosis, occurring within 72 h
after subarachnoid hemorrhage (SAH), is associated with the prognosis of SAH. Recent …

Stroke is a leading cause of mortality and morbidity worldwide. Understanding the
underlying mechanisms is important for developing effective therapies for treating stroke …

There are many situations of excessive production of reactive oxygen species (ROS) such
as radiation, ischemia/reperfusion (I/R), and inflammation. ROS contribute to and arises from …

Traumatic brain injury (TBI) is a major cause of chronic disability and death in young adults
worldwide. Multiple cellular, molecular and biochemical changes impact the development …

Cells of an organism face with various types of insults during their lifetime. Exposure to
toxins, metabolic problems, ischaemia/reperfusion, physical trauma, genetic diseases …

Oxidative stress and neuroinflammation cause many neurological disorders. Recently, it has
been reported that molecular hydrogen (H2) functions as an antioxidant and anti …

Acute as well as chronic disorders of the nervous system lead to significant morbidity and
mortality for millions of individuals globally. Given the ability to govern stem cell proliferation …